NOLAN SEAN P. sold 5.8% of their position (178.10K shares) of TAYSHA GENE THERAPIES, INC. on the open market
Open‑market sale worth $840.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/27/2026ACC: 0001569926-26-000008
-178.10K
Net shares
Net seller
$840.2K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
178.10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−136.79K
Price / share
$4.75
Trade value
$649.75K
% of position
4.4%
1/23/2026
3.09M→2.95M
Common Stock
Direct
Shares
−41.31K
Price / share
$4.61
Trade value
$190.45K
% of position
1.4%
1/26/2026
2.95M→2.91M
Total
Net shares
−178.10K
Net value
-$840.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/23/2026 | S · Sale | −136.79K | $4.75 | $649.75K | 4.4% | 3.09M | 2.95M |
| Common Stock Direct | 1/26/2026 | S · Sale | −41.31K | $4.61 | $190.45K | 1.4% | 2.95M | 2.91M |
| Total | −178.10K | -$840.20K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.54M
Total
1.54M indirect1.54M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.54M | Indirect |
| Total | 1.54M | 1.54M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported